Evidence map›Paper›PMID 25500883›Full record

ArticleThe Journal of clinical investigation2015

Defective removal of ribonucleotides from DNA promotes systemic autoimmunity.

Claudia Günther, Barbara Kind, Martin A M Reijns, Nicole Berndt, Manuel Martinez-Bueno, Christine Wolf, Victoria Tüngler, Osvaldo Chara, Young Ae Lee, Norbert Hübner and 35 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 135 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
135citing papers in PubMed, 2 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

135 citing papers in PubMed, 2 syntheses or guidelines pooled it, 218 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

75 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

45 authors at 16 institutions in 4 countries.

Claudia Günther
Barbara Kind
Martin A M Reijns
Nicole Berndt
Manuel Martinez-Bueno
Christine Wolf
Victoria Tüngler
Osvaldo Chara
Young Ae Lee
Norbert Hübner
Louise Bicknell
Sophia Blum
Claudia Krug
Franziska Schmidt
Stefanie Kretschmer
Sarah Koss
Katy R Astell
Georgia Ramantani
Anja Bauerfeind
David L Morris
Deborah S Cunninghame Graham
Doryen Bubeck
Andrea Leitch
Stuart H Ralston
Elizabeth A Blackburn
Manfred Gahr
Torsten Witte
Timothy J Vyse
Inga Melchers
Elisabeth Mangold
Markus M Nöthen
Martin Aringer
Annegret Kuhn
Kirsten Lüthke
Leonore Unger
Annette Bley
Alice Lorenzi
John D Isaacs
Dimitra Alexopoulou
Karsten Conrad
Andreas Dahl
Axel Roers
Marta E Alarcon-Riquelme
Andrew P Jackson
Min Ae Lee-Kirsch
University Hospital Carl Gustav Carus · DETU Dresden · DEMRC Institute of Genetics and Molecular Medicine · GBMax Delbrück Center · DENewcastle University · GBGerman Center for Neurodegenerative Diseases · DEImperial College London · GBMedizinische Hochschule Hannover · DEOklahoma Medical Research Foundation · USPraxis für Hämatologie und Onkologie · DEStädtisches Klinikum Dresden · DEUniversität Hamburg · DEUniversity Medical Center Freiburg · DEUniversity of Bonn · DEUniversity of Edinburgh · GBUniversity of Freiburg · DE

Funding

DNA VACCINE MEDIATED IMMUNOTHERAPY OF RHEUMATIC DISEASEK08AR002133 · NIAMS · STANFORD UNIVERSITY · PI ROBINSON, WILLIAM H · 2000 to 2004
$566k
Biotechnology and Biological Sciences Research CouncilMedical Research Council MC_PC_U127580972NIAMS NIH HHS K08 AR002133Versus Arthritis 19289Wellcome Trust
6 · The paper itself

Abstract

Genome integrity is continuously challenged by the DNA damage that arises during normal cell metabolism. Biallelic mutations in the genes encoding the genome surveillance enzyme ribonuclease H2 (RNase H2) cause Aicardi-Goutières syndrome (AGS), a pediatric disorder that shares features with the autoimmune disease systemic lupus erythematosus (SLE). Here we determined that heterozygous parents of AGS patients exhibit an intermediate autoimmune phenotype and demonstrated a genetic association between rare RNASEH2 sequence variants and SLE. Evaluation of patient cells revealed that SLE- and AGS-associated mutations impair RNase H2 function and result in accumulation of ribonucleotides in genomic DNA. The ensuing chronic low level of DNA damage triggered a DNA damage response characterized by constitutive p53 phosphorylation and senescence. Patient fibroblasts exhibited constitutive upregulation of IFN-stimulated genes and an enhanced type I IFN response to the immunostimulatory nucleic acid polyinosinic:polycytidylic acid and UV light irradiation, linking RNase H2 deficiency to potentiation of innate immune signaling. Moreover, UV-induced cyclobutane pyrimidine dimer formation was markedly enhanced in ribonucleotide-containing DNA, providing a mechanism for photosensitivity in RNase H2-associated SLE. Collectively, our findings implicate RNase H2 in the pathogenesis of SLE and suggest a role of DNA damage-associated pathways in the initiation of autoimmunity.

Indexed as

DNA RepairAutoimmunityCell ProliferationCells, CulturedDNA Mutational AnalysisGene ExpressionHeterozygoteHumansInterferon Type ILupus Erythematosus, SystemicPyrimidine DimersRibonuclease HInterferon Type IPyrimidine DimersRibonuclease Hribonuclease HII

Identifiers

PMID25500883
PMCPMC4382239
OpenAlexW2149355104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.